利福霉素-O

利福霉素-O性质、用途与生产工艺

用途

利福霉素-O 上下游产品信息

上游原料

下游产品

利福霉素-O 生产厂家

14487-05-9, 利福霉素-O 相关搜索:

• Pharmaceuticals
• Intermediates & Fine Chemicals
• Chiral Reagents
• 杂质对照品
• 抑制剂
• 科研原料
• 精细化工原料
• 试剂
• 医用原料
• 化学试剂
• 利福昔明杂质
• 化学试剂-科研试剂
• 原料药
• 医药原料
• C39H47NO14
• 化合物 SPIRO[1,3-DIOXOLANE-2,9'(6'H)-[2,7](EPOXYPENTADECA[1,11,13]TRIENIMINO)NAPHTHO[2,1-B]FURAN]-1',4,6',11'(2'H)-TETRONE, 5',17',19',21'-TETRAHYDROXY-23'-METHOXY-2',4',12',16',18',20',22'-HEPTAMETHYL-21'-ACETATE
• 化合物 SPIRO[1,3-DIOXOLANE-2,9'(6'H)-[2,7](EPOXYPENTADECA[1,11,13]TRIENIMINO)NAPHTHO[2,1-B]FURAN]-1',4,6',11'(2'H)-TETRONE, 5',17',19',21'-TETRAHYDROXY-23'-METHOXY-2',4',12',16',18',20',22'-HEPTAMETHY
• 利福昔明杂质6(利福昔明EP杂质F)
• 利福霉素, 4-O-(羧基甲基)-1-脱氧-1,4-二氢-4-羟基-1-氧代-, Γ-内酯 (9CI, ACI)
• 螺[1,3-二氧戊环-2,9'(6'H)-[2,7](环氧十五碳环[1,11,13]三烯亚氨基)萘并[2,1-B]呋喃]-1',4,6',11'(2'H)-四酮, 5',17',19',21'-四羟基-23'-甲氧基-2',4',12',16',18',20',22'-七甲基-21'-乙酸酯
• 利福昔明EP杂质F(利福霉素EP杂质C)
• 螺[1,3-二氧戊环-2,9'(6'H)-[2,7](环氧十五碳环[1,11,13]三烯亚氨基)萘并[2,1-B]呋喃]-1',4,6',11'(2'H)-四酮, 5',17',19',21'-四羟基-23'-甲氧基-2',4',12',1
• 利福霉素EP杂质F
• 利福昔明杂质F (EP/BP)
• 利福昔明EP杂质F
• 利福霉素0
• 螺[1,3-二氧戊环-2,9'(6'H)-[2,7](环氧十五碳环[1,11,13]三烯亚氨基)萘并[2,1-B]呋喃]-1',4,6',11'(2'H)-四酮, 5',17',19',21'-四羟基-23'-甲氧基-2',4',12',16',18',20',22'-七甲基-21'-乙酸酯
• 利福昔明EP杂质F(利福霉素O)
• 利福霉素O
• 利福霉素-O
• 二恶酮利福霉素
• 14487-05-9
• Levofloxacin O
• Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan]-1',4,6',11'(2'H)-tetrone, 5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-21'-acetate
• Rifaximin EP Impurity F（Rifamycin EP Impurity C）
• 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-Rifamycin γ-lactone (9CI ACI)
• Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone (9CI, ACI)
• Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan]-1',4,6',11'(2'H)-tetrone, 5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-21'-acetate
• Rifamycin O USP/EP/BP
• Rifamycin Impurity 3(Rifamycin EP Impurity C)（Rifamycin O)
• Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, γ-lactone
• Rifaximin EP Impurity F (Rifamycin O)
• Rifamycin EP Impurity C
• Rifaximin Impurity 6 (Rifaximin EP Impurity F)
• Rifaximin impurity F (EP)
• 4-o-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycigamma-la
• 4’,12’,16’,18’,20’,22’-heptamethyl--221’-acetate
• 2,1-b)furan)-1’,4,6’,11’(2’h)-tetrone,5’,17’,19’,21’-tetrahydroxy-23’-methoxy
• RIFAMYCIN O
• Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, gamma-lactone
• Rifaximin EP Impurity F
• RifaMycin,4-O-(carboxyMethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, g-lactone
• 4-O-(CARBOXYMETHYL)-1-DEOXY-1,4-diHYDRO-4-HYDROXY-1-OXO-G-LACTONE
• NSC 182391
• Rifomycin O
• 4-O-Carboxymethyl-1-deoxy-1,4-dihydro-4-hydroxy-1-oxorifamycin γ-lactone
• spiro(1,3-dioxolane-2,9’(6’h)-(2,7)(epoxypentadeca(1,11,13)trienimino)naphtho(
• ctone